关于在特发性和遗传性肺静脉闭塞病中使用类固醇和霉酚酸酯的病例系列研究：免疫抑制是否起作用？ - Suppr | 超能文献

相似文献

1

A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?关于在特发性和遗传性肺静脉闭塞病中使用类固醇和霉酚酸酯的病例系列研究：免疫抑制是否起作用？

Eur Respir J. 2021 Jun 24;57(6). doi: 10.1183/13993003.04354-2020. Print 2021 Jun.

2

Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation.活体供体肺叶移植术后成功停用霉酚酸酯的两例病例报告。

Transplant Proc. 2013 Jan-Feb;45(1):356-9. doi: 10.1016/j.transproceed.2012.09.112.

3

Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.肺移植后环孢素A与他克莫司联合霉酚酸酯及类固醇作为初始免疫抑制治疗的比较：一项2中心前瞻性随机试验的一年结果

J Thorac Cardiovasc Surg. 2003 Apr;125(4):891-900. doi: 10.1067/mtc.2003.71.

4

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients.肾移植受者使用他克莫司和霉酚酸酯进行初始免疫抑制治疗。

Transplantation. 1998 Jan 27;65(2):248-52. doi: 10.1097/00007890-199801270-00018.

5

Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation.他克莫司和霉酚酸酯在大鼠喉移植中提供有效的免疫抑制作用。

Laryngoscope. 2003 Aug;113(8):1308-13. doi: 10.1097/00005537-200308000-00009.

6

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.肝移植后无类固醇免疫抑制的新型管理策略：他克莫司和霉酚酸酯的疗效与安全性

Transplantation. 2001 Feb 27;71(4):508-15. doi: 10.1097/00007890-200102270-00005.

7

Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.心脏移植后他克莫司联合霉酚酸酯或西罗莫司与钙调神经磷酸酶抑制剂免抑制（西罗莫司/霉酚酸酯）比较：5 年结果。

J Heart Lung Transplant. 2013 Mar;32(3):277-84. doi: 10.1016/j.healun.2012.11.028.

8

Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.他克莫司和霉酚酸酯方案与传统类固醇疗法对肝移植患者心血管风险的影响。

Clin Transplant. 2015 Aug;29(8):667-77. doi: 10.1111/ctr.12557. Epub 2015 Jun 29.

9

Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation.

Transpl Int. 2000;13 Suppl 1:S191-4. doi: 10.1007/s001470050323.

10

Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.加拿大肾移植中他克莫司/硫唑嘌呤/类固醇与他克莫司/霉酚酸酯/类固醇以及新山地明/霉酚酸酯/类固醇的多中心试验。

Transplant Proc. 2001 Feb-Mar;33(1-2):1266-7. doi: 10.1016/s0041-1345(00)02471-4.

引用本文的文献

1

Pulmonary veno-occlusive disease: a clinical review.肺静脉闭塞性疾病：临床综述

Breathe (Sheff). 2025 Mar 18;21(1):240098. doi: 10.1183/20734735.0098-2024. eCollection 2025 Jan.

2

Pulmonary veno-occlusive disease: illustrative cases and literature review.肺静脉闭塞病：病例举例与文献复习。

Eur Respir Rev. 2024 Jan 17;33(171). doi: 10.1183/16000617.0156-2023. Print 2024 Jan 31.

3

Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.自体干细胞移植后肺静脉闭塞病